About the Programme

What is asthma? PIPPA Tamariki illustrations

Asthma is one of the most common childhood illnesses in New Zealand, affecting thousands of children each year. Many of these children go on to have life-long asthma and other allergic conditions. Despite improvements in medical care, the number of children with asthma remains very high. Experts don’t know why this is happening.


Most babies are given medicines for pain or fever, such as paracetamol (Pamol, Paracare) or ibuprofen (Brufen, Nurofen), at some stage in their first year.  Paracetamol and ibuprofen are safe and effective at relieving pain and fever in babies, but no-one knows if their use influences the chances of developing asthma or not.

This study will find out if there are different rates of asthma at 6 years of age in children who just take paracetamol when they are unwell in their first 12 months of life, compared to children who just take ibuprofen.

How can I help?


What does the PIPPA Tamariki involve?

Upon enrolling, you are assigned a group – either Paracetamol or Ibuprofen. If your baby has a fever or pain and needs medicine: give the one that you have been assigned to, which we will provide freely. You will complete short surveys about how your baby is doing in their first year and twice more at age 3 and 6 years old.

Benefits of taking part

Benefits of participation in the PIPPA Tamariki study

How can I register my interest?

If you are expecting a baby or have recently given birth and would like to discuss enrolling in the study: please fill this form or contact us by email and a member of the team will get in touch soon.